Skip to main content

Table 1 Baseline demographic data for women diagnosed with endometriosis treated with either simvastatin (simvastatin group) or placebo (control group)

From: Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial

Characteristics Control group (N = 20) Simvastatin group (N = 20) P value
Age, mean ± SD (years) 31.05 ± 5.21 30.7± 5.07 0.83
BMI, mean ± SD (kg/m2) 20.91 ± 4.24 20.44 ± 3.43 0.71
Parity, N(%) 0 20 (100%)
0 (0%)
17 (88.24%)
3 (11.76%)
0.23
1
Duration of menstruation, mean ± SD (days) 4.4 ± 1.46 4.8 ± 1.11 0.36
Interval of menstruation, mean ± SD (days) 29.55 ± 1.73 28.8 ± 2.91 0.33
Infertility, N(%) Yes 10 (50%)
10 (50%)
7 (47%)
13 (53%)
0.52
No
Stage of endometriosis, N(%) III 7 (35%)
13 (65%)
7 (35.5%)
13 (65%)
1.00
IV
  1. BMI body mass index